RhoC is essential for the metastasis of gastric cancer

Journal of Molecular Medicine

Volumn 85, Issue 10, 2007, Pages 1149-1156

  Liu, Na ^a   Zhang, Guoyun ^a   Bi, Feng ^a   Pan, Yanglin ^a   Xue, Yan ^a   Shi, Yongquan ^a   Yao, Liping ^a   Zhao, Lina ^a   Zheng, Yi ^b   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Gastric cancer; Metastasis; Rho GTPase; siRNA

Indexed keywords

RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER DIAGNOSIS; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION INHIBITION TEST; METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SIMIAN VIRUS 40; STAINING; STOMACH CANCER; STOMACH EPITHELIUM; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RHO GTP-BINDING PROTEINS; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

EID: 34748842710     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0217-y     Document Type: Article

References (35)

1. Alberts SR, Cervantes A, van de Velde CJ (2003) Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14(2):ii31-36
2. Roder DM (2002) The epidemiology of gastric cancer. Gastric Cancer 5(1):5-11
3. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420(6916):629-635
4. Sahai E, Marshall CJ (2002) Rho-GTPases and cancer. Nat Rev 2:133-142
5. Fritz G, Just I, Kaina B (1999) Rho GTPases are over-expressed in human tumors. Int J Cancer 819(5):682-687
6. Kamai T, Arai K, Tsujii T, Honda M, Yoshida K (2001) Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int 87(3):227-231
7. Kamai T, Tsujii T, Arai K et al (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9(7):2632-2641
8. Horiuchi A, Imai T, Wang C et al (2003) Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83(6):861-870
9. Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y, Yoshida K (2004) Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 10(14):4799-4805
10. Adnane J, Muro-Cacho C, Mathews L, Sebti SM, Munoz-Antonia T (2002) Suppression of rho B expression in invasive carcinoma from head and neck cancer patients. Clin Cancer Res 8(7):2225-2232
11. Jiang K, Delarue FL, Sebti SM (2004) EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation. Oncogene 23(5):1136-1145
12. Prendergast GC (2001) Actin' up: RhoB in cancer and apoptosis. Nat Rev Cancer 1(2):162-168
13. Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406(6795):532-535
14. Liu N, Bi F, Pan Y et al (2004) Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 10(18):6239-6247 (Pt 1)
15. Xue Y, Bi F, Zhang X, Zhang S, Pan Y, Liu N, Shi Y, Yao X, Zheng Y, Fan D (2006) Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation. Int J Cancer 118(12):2965-2972
16. Wherlock M, Mellor H (2002) The Rho GTPase family: a Racs to Wrchs story. J Cell Sci 115(2):239-240
17. van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD (2002) Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin Exp Metastasis 19(4):301-311
18. del Peso L, Hernandez-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C, Lacal JC (1997) Rho proteins induce metastatic properties in vivo. Oncogene 15(25):3047-3057
19. Kjoller L, Hall A (1999) Signaling to Rho GTPases. Exp Cell Res 253(1):166-179 (Nov 25)
20. Suwa H, Ohshio G, Imamura T, Watanabe G, Arii S, Imamura M, Narumiya S, Hiai H, Fukumoto M (1998) Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77(1):147-152
21. Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ (2003) Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 9(9):1950-1953
22. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B, Stamp G, Baron A, Scarpa A, Lemoine NR (2002) Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21(29):4587-4594
23. van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD (1999) A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5(9):2511-2519
24. Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD (2005) RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Res Treat 93(2):101-110
25. Shikada Y, Yoshino I, Okamoto T, Fukuyama S, Kameyama T, Maehara Y (2003) Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Clin Cancer Res 9(14):5282-5286
26. Faried A, Faried LS, Kimura H, Nakajima M, Sohda M, Miyazaki T, Kato H, Usman N, Kuwano H (2006) RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo. Eur J Cancer 42(10):1455-1465
27. Ikoma T, Takahashi T, Nagano S, Li YM, Ohno Y, Ando K, Fujiwara T, Fujiwara H, Kosai K (2004) A definitive role of RhoC in metastasis of orthotopic lung cancer in mice. Clin Cancer Res 10(3):1192-1200
28. Mukai M, Endo H, Iwasaki T, Tatsuta M, Togawa A, Nakamura H, Inoue M (2006) RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells. Biochem Biophys Res Commun 346(1):74-82
29. Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R, Mak TW (2005) RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 19(17):1974-1979
30. Simpson KJ, Dugan AS, Mercurio AM (2004) Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res 64(23):8694-8701
31. Bellovin DI, Simpson KJ, Danilov T, Maynard E, Rimm DL, Oettgen P, Mercurio AM (2006) Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 25:6959-6967
32. Pille JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C, Soria C, Li H (2005) Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 11(2):267-274
33. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD (2000) RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60(20):5832-5838
34. Reddig PJ, Juliano RL (2005) Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 24(3):425-439
35. Wang LH (2004) Molecular signaling regulating anchorage-independent growth of cancer cells. Mt Sinai J Med 71(6):361-367